changing your setting. We'll assume that you are happy to receive all cookies on the BTG website.
Treat PE with EKOS™
The EKOS® Control Unit 4.0 is designed to support a new standard of PE treatment – allowing physicians to use one control unit to treat both pulmonary arteries
The EKOS Control Unit 4.0 is not available for sale in all countries
Read the SEATTLE II and OPTALYSE PE study results in our Learning Center
Find your PE Resources here
Learn more about our ongoing collaborations in research trials.
Review successful EKOS™ case studies for treatment of PE, DVT and PAO.
Did you know EKOS™ System is the first device cleared by the FDA for the treatment of
ULTIMA Trial Summary
SEATTLE II Trial Summary
OPTALYSE PE Trial Summary
Society of Critical Care Medicine (SCCM)
Chronic Total Occlusion Summit
American Venous Forum (AVF)
BOSTON SCIENTIFIC CLOSES ACQUISITION OF ...
Venous Leg Ulcer Registry Shows Promisin...
BTG Sentry Bioconvertible IVC Filter 2-y...
OPTALYSE PE Results Presented at Society...
Healthcare Player BTG on lookout for acq...
NICE highlights potential role of TheraS...
Select CONTINUE to proceed to the BTG website or LEAVE to learn more at BSC.com